New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

41

Do not assume COVID pandemic reaching ‘end game’, warns WHO

The head of the World Health Organization (WHO) warned on Jan. 24 that it was dangerous to assume the Omicron variant would herald the end of COVID-19’s acutest phase, exhorting nations to stay focused to beat the pandemic.

42

1 in 5 Americans Have had COVID-19, Veklury Approved in New Indication

At least 1 in 5 Americans have been infected with COVID-19. In other news, the U.S. Food and Drug Administration approved Gilead Sciences’ supplemental New Drug Application for Veklury (remdesivir) for adults and adolescents with COVID-19 who are not hospitalized but are at high risk of progression to severe COVID-19, hospitalization or death.

47

U.S. FDA Approves Second Indication for Skyrizi to Treat Adults with Active Psoriatic Arthritis

The U.S. Food and Drug Administration approved AbbVie’s Skyrizi (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), a systemic inflammatory disease that affects the skin and joints and impacts 30 percent of patients with psoriasis.

48

U.S. studies highlight the need for COVID boosters to fight Omicron

Three U.S. studies show that a third dose of an mRNA vaccine is key to fighting the Omicron coronavirus variant, providing 90% protection against hospitalization due to COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) said on January 21.